Moderna Inc (NASDAQ:MRNA)
| 147.66 Delayed Data As of May 27 |  +11.86 / +8.73%Today’s Change | 119.01 Today|||52-Week Range 497.49 | -41.86% Year-to-Date |
Latest MRNA News | Press Releases
| Will This Beaten-Down Stock Bounce Back? 3 Things to Know May 28 / MotleyFool.com - Paid Partner Content | 2 Struggling Stocks That Aren't Likely to Recover Anytime Soon May 26 / MotleyFool.com - Paid Partner Content |
| Why Moderna Stock Is Jumping Today May 27 / MotleyFool.com - Paid Partner Content | Better Buy Ahead of FDA Meetings: Moderna vs. Novavax May 25 / MotleyFool.com - Paid Partner Content |
| Knowing This Number Can Save Your Portfolio From Disaster May 27 / MotleyFool.com - Paid Partner Content | 4 Nasdaq 100 Stocks Billionaires Piled Into During the First Quarter May 25 / MotleyFool.com - Paid Partner Content |
| Why Novavax Was Tumbling by 12% This Week May 26 / MotleyFool.com - Paid Partner Content | AstraZeneca (AZN) Gets EU Nod for COVID-19 Booster Shot May 24 / Zacks.com - Paid Partner Content |
| Theleme Partners LLP's Top 5 Buys of the 1st Quarter May 26 / GuruFocus News - Paid Partner Content | Ocugen (OCGN) Covaxin Studies Clinical Hold Lifted by FDA May 24 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 135.80 |
| Today’s open | 137.38 |
| Day’s range | 136.59 - 148.54 |
| Volume | 7,590,709 |
| Average volume (3 months) | 7,370,225 |
| Market cap | $58.7B |
Data as of 05/27/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -1.44% |
| Earnings growth (next 5 years) | -37.83% |
| Revenue growth (last year) | +2,191.90% |
| P/E ratio | -- |
| Price/Sales | 5.95 |
| Price/Book | 4.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | +14.49 | +5.95% |
| GILDGilead Sciences | +0.33 | +0.51% |
| BIIBBiogen | +1.98 | +0.97% |
| ---- |
Data as of 05/27/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | $4.74 |
| Annual revenue (last year) | $18.4B |
| Annual profit (last year) | $12.2B |
| Net profit margin | 66.27% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
